These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11137456)
1. Characterization of a prolyl endopeptidase (kininase) from human urine using fluorogenic quenched substrates. Quinto BM; Juliano MA; Hirata I; Carmona AK; Juliano L; Casarini DE Int J Biochem Cell Biol; 2000; 32(11-12):1161-72. PubMed ID: 11137456 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a kinin inactivating serine endopeptidase H2 (kininase) from human urine using fluorogenic substrates. Quinto BM; Juliano L; Juliano M; Carmona AK; Stella RC; Casarini DE Immunopharmacology; 1999 Dec; 45(1-3):223-8. PubMed ID: 10615015 [TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a neutral endopeptidase-like enzyme from human urine. Di Marco GS; Quinto BM; Juliano M; Carmona AK; Stella RC; Plavnik FL; Casarini DE J Hypertens; 1998 Dec; 16(12 Pt 2):1971-8. PubMed ID: 9886885 [TBL] [Abstract][Full Text] [Related]
4. Specificity comparison of a serine endopeptidase (SH1) and a serine thiol endopeptidase (STH2) purified from human urine. Quinto BM; Juliano MA; Hirata I; Carmona AK; Juliano L; Casarini DE Int J Biochem Cell Biol; 2004 Oct; 36(10):1933-44. PubMed ID: 15203108 [TBL] [Abstract][Full Text] [Related]
5. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein. El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides. Melo RL; Alves LC; Del Nery E; Juliano L; Juliano MA Anal Biochem; 2001 Jun; 293(1):71-7. PubMed ID: 11373081 [TBL] [Abstract][Full Text] [Related]
7. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11). Oliveira V; Campos M; Hemerly JP; Ferro ES; Camargo AC; Juliano MA; Juliano L Anal Biochem; 2001 May; 292(2):257-65. PubMed ID: 11355859 [TBL] [Abstract][Full Text] [Related]
10. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Araujo MC; Melo RL; Cesari MH; Juliano MA; Juliano L; Carmona AK Biochemistry; 2000 Jul; 39(29):8519-25. PubMed ID: 10913258 [TBL] [Abstract][Full Text] [Related]
11. Specific fluorogenic substrates for neprilysin (neutral endopeptidase, EC 3.4.24.11) which are highly resistant to serine- and metalloproteases. Medeiros MA; França MS; Boileau G; Juliano L; Carvalho KM Braz J Med Biol Res; 1997 Oct; 30(10):1157-62. PubMed ID: 9496431 [TBL] [Abstract][Full Text] [Related]
12. Met-Lys-bradykinin-Ser, the kinin released from human kininogen by human pepsin. Silva RA; Chagas JR; Juliano L; Hial V Immunopharmacology; 1996 May; 32(1-3):76-9. PubMed ID: 8796271 [TBL] [Abstract][Full Text] [Related]
13. Liver bradykinin-inactivating-endopeptidase is similar to the metalloendopeptidase (EC 3.4.24.15). Molina HM; Carmona AK; Kouyoumdjian M; Borges DR; Juliano L Immunopharmacology; 1996 May; 32(1-3):176-9. PubMed ID: 8796302 [TBL] [Abstract][Full Text] [Related]
14. Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase. Camargo AC; Gomes MD; Reichl AP; Ferro ES; Jacchieri S; Hirata IY; Juliano L Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):517-22. PubMed ID: 9182712 [TBL] [Abstract][Full Text] [Related]
15. Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity. Hemerly JP; Oliveira V; Del Nery E; Morty RE; Andrews NW; Juliano MA; Juliano L Biochem J; 2003 Aug; 373(Pt 3):933-9. PubMed ID: 12737623 [TBL] [Abstract][Full Text] [Related]
16. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney. Gomes RA; Juliano L; Chagas JR; Hial V Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments. Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318 [TBL] [Abstract][Full Text] [Related]
18. Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase. Gorrão SS; Hemerly JP; Lima AR; Melo RL; Szeltner Z; Polgár L; Juliano MA; Juliano L Peptides; 2007 Nov; 28(11):2146-54. PubMed ID: 17904692 [TBL] [Abstract][Full Text] [Related]
19. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins. Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788 [TBL] [Abstract][Full Text] [Related]
20. A highly selective assay for neutral endopeptidase based on the cleavage of a fluorogenic substrate related to Leu-enkephalin. Carvalho KM; Boileau G; Camargo AC; Juliano L Anal Biochem; 1996 Jun; 237(2):167-73. PubMed ID: 8660561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]